Anti-CD39 mAb publication in Cell Reports
Meet us at the 2019 ASCO annual meeting in Chicago
17 June 2019
Dr Bonnefoy to inaugurate first CyTOF Hyperion in France
17 September 2019
The publication of preclinical data of the CD39-blocking monoclonal antibody IPH5201 appears in the May 21, 2019 issue of the journal Cell Reports.
Read the full manuscript titled “Blocking antibodies targeting the CD39/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies”
